Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 12, Issue 2, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-04
DOI
10.1038/s41419-021-03434-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AURKB promotes gastric cancer progression via activation of CCND1 expression
- (2020) Min Nie et al. Aging-US
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Influence of remoteness of residence on timeliness of diagnosis and treatment of oral cavity and oropharynx cancer: A retrospective cohort study
- (2020) Rebecca L Venchiarutti et al. Journal of Medical Imaging and Radiation Oncology
- Tanshinone IIA Improves Depression-like Behavior in Mice by Activating the ERK-CREB-BDNF Signaling Pathway
- (2020) Jiaqi Lu et al. NEUROSCIENCE
- Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization
- (2020) Feng Gao et al. Cell Death & Disease
- Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma
- (2020) Ming Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Relapse-associated AURKB blunts the glucocorticoid sensitivity of B cell acute lymphoblastic leukemia
- (2019) Coralie Poulard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination of tanshinone IIA and doxorubicin possesses synergism and attenuation effects on doxorubicin in the treatment of breast cancer
- (2019) Kun Li et al. PHYTOTHERAPY RESEARCH
- Tanshinone IIA combined with cisplatin synergistically inhibits non‐small‐cell lung cancer in vitro and in vivo via down‐regulating the phosphatidylinositol 3‐kinase/Akt signalling pathway
- (2019) Xiao‐Zhong Liao et al. PHYTOTHERAPY RESEARCH
- AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy
- (2019) Jordi Bertran-Alamillo et al. Nature Communications
- Selective inhibition of Aurora A and B kinases effectively induces cell cycle arrest in t(8;21) acute myeloid leukemia
- (2019) Jialei Qi et al. BIOMEDICINE & PHARMACOTHERAPY
- Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin
- (2019) Xinfang Yu et al. ONCOGENE
- Tanshinone IIA Reverses Oxaliplatin Resistance In Human Colorectal Cancer Via Inhibition Of ERK/Akt Signaling Pathway
- (2019) Yonggang Zhang et al. OncoTargets and Therapy
- Tanshinone IIA Reverses Gefitinib-Resistance In Human Non-Small-Cell Lung Cancer Via Regulation Of VEGFR/Akt Pathway
- (2019) Rui Wang et al. OncoTargets and Therapy
- Regulation of cell cycle by MDM2 in prostate cancer cells through Aurora Kinase-B and p21WAF1/CIP1 mediated pathways
- (2019) Thanigaivelan Kanagasabai et al. CELLULAR SIGNALLING
- Oral Cancer
- (2019) Chia-Cheng Li et al. Surgical Oncology Clinics of North America
- Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth
- (2019) Li Zhou et al. EBioMedicine
- Follow-up after curative treatment for oral squamous cell carcinoma. A critical appraisal of the guidelines and a review of the literature
- (2018) M.T. Brands et al. EJSO
- Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells
- (2018) Chien-Ming Chiu et al. OncoTargets and Therapy
- Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity
- (2018) Yuanfeng Zhou et al. International Journal of Biological Sciences
- The functional diversity of Aurora kinases: a comprehensive review
- (2018) Estelle Willems et al. Cell Division
- Tanshinone sensitized the antitumor effects of irradiation on laryngeal cancer via JNK pathway
- (2018) Hui Xu et al. Cancer Medicine
- AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS
- (2018) Hou Dawei et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The anticancer mechanism investigation of Tanshinone IIA by pharmacological clustering in protein network
- (2018) Yan-feng Cao et al. BMC Systems Biology
- Anti-mitotic therapies in cancer
- (2018) Julia Tischer et al. JOURNAL OF CELL BIOLOGY
- Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival
- (2018) Matthew G. Oser et al. Cancer Discovery
- A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies
- (2017) Ankit C. Borisa et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- CHK2 overexpression and mislocalisation within mitotic structures enhances chromosomal instability and hepatocellular carcinoma progression
- (2017) Vinicio Carloni et al. GUT
- Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis By Epigenetically Reactivating the p53 Pathway
- (2017) Lian Zheng et al. ONCOLOGY RESEARCH
- Aurora kinases: novel therapy targets in cancers
- (2017) Anqun Tang et al. Oncotarget
- Oxymatrine inhibits non-small cell lung cancer via suppression of EGFR signaling pathway
- (2017) Wei Li et al. Cancer Medicine
- Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma
- (2017) Xinfang Yu et al. EBioMedicine
- Aurora B Expression as a Prognostic Indicator and Possibile Therapeutic Target in Oral Squamous Cell Carcinoma
- (2017) G. Pannone et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Tanshinone IIA sensitizes oral squamous cell carcinoma to radiation due to an enhanced autophagy
- (2016) Lijuan Ding et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Tanshinone IIA enhances chemosensitivity of colon cancer cells by suppressing nuclear factor-κB
- (2016) YANGQIU BAI et al. Experimental and Therapeutic Medicine
- EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis
- (2016) Haidan Liu et al. Oncotarget
- Daurinol Enhances the Efficacy of Radiotherapy in Lung Cancer via Suppression of Aurora Kinase A/B Expression
- (2015) J. K. Woo et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of Tanshinone IIA, Salvianolic Acid A and Salvianolic Acid B on Areca Nut Extract-Induced Oral Submucous Fibrosis in Vitro
- (2015) Jian-Ping Dai et al. MOLECULES
- Inhibition of Aurora B by CCT137690 sensitizes colorectal cells to radiotherapy
- (2014) Xiaoyu Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
- (2012) Yong Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now